Stockreport

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

LENZ Therapeutics, Inc.  (LENZ) 
PDF Capstone data from Phase 3 CLARITY study to be presented Event to feature Key Opinion Leader and Principal Investigator perspectives on LNZ100 potential in presbyopia [Read more]